Trish Costello and Fund leads Nola, Darshana and Faz discuss the FemTech market landscape and fund strategy.
Aria CV is a medical device company with an implant for the treatment of pulmonary arterial hypertension (PAH), which causes right-sided heart failure.
Solace Therapeutics & Aria Evaluation and Discussion
Elidah & Bone Health Technologies Evaluation and Discussion
Bone Health Technologies is a medical device company that has developed a product called Osteoboost.
Sana Health is redefining the way pain is being treated with a non-invasive device helping patients manage chronic pain.
Pitch evaluation and discussion of Joylux and EasyFlo by fund leadership and Portfolia FemTech fund members.
Tivic Health offers bioelectric treatment for chronic sinus pain and pressure, which affects over 30M people in the US alone.
Pitch evaluation and discussion of Tivic and Uvision 360 by fund leadership and Portfolia FemTech fund members.
Madorra has developed the first effective, non- hormonal treatment and new treatment paradigm for vaginal dryness.
Pitch evaluation and discussion of Madorra and Palmm by fund leadership and Portfolia FemTech fund members.
Future Family helps families more easily afford fertility services like IVF and egg freezing.
The highlights of Q2 2021 updates as provided by the companies. Please note all updates provided are confidential and not for distribution.
Read the report